LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 23.10 | 84.90 | 40 | 1616 | 0.0247 | -0.1623 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 23.10 | 84.90 | 1174 | 1616 | 0.7264 | 0.8551 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.81 | 84.90 | 13 | 1769 | 0.0073 | -0.3484 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.81 | 84.90 | 968 | 1769 | 0.5471 | 0.7428 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.81 | 84.90 | 50 | 1769 | 0.0283 | -0.1138 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.81 | 84.90 | 1224 | 1769 | 0.6917 | 0.8386 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 26.51 | 84.90 | 13 | 1923 | 0.0068 | -0.3409 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 26.51 | 84.90 | 985 | 1923 | 0.5122 | 0.7238 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 26.51 | 84.90 | 55 | 1923 | 0.0286 | -0.0919 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 26.51 | 84.90 | 1249 | 1923 | 0.6495 | 0.8171 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 28.21 | 84.90 | 14 | 2091 | 0.0067 | -0.3229 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 28.21 | 84.90 | 1032 | 2091 | 0.4934 | 0.7166 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 28.21 | 84.90 | 75 | 2091 | 0.0359 | -0.0265 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 28.21 | 84.90 | 1295 | 2091 | 0.6192 | 0.8030 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.92 | 84.90 | 32 | 2237 | 0.0143 | -0.1867 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.92 | 84.90 | 1063 | 2237 | 0.4750 | 0.7082 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.92 | 84.90 | 78 | 2237 | 0.0349 | -0.0178 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.92 | 84.90 | 1339 | 2237 | 0.5984 | 0.7938 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 31.62 | 84.90 | 21 | 2449 | 0.0086 | -0.2502 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 31.62 | 84.90 | 1093 | 2449 | 0.4462 | 0.6935 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 31.62 | 84.90 | 114 | 2449 | 0.0465 | 0.0627 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 31.62 | 84.90 | 1376 | 2449 | 0.5617 | 0.7758 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 33.32 | 84.90 | 34 | 2722 | 0.0125 | -0.1672 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 33.32 | 84.90 | 1140 | 2722 | 0.4188 | 0.6806 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 33.32 | 84.90 | 122 | 2722 | 0.0448 | 0.0752 | MN20160318_Q02 | L16 |